HQH:NYE-Tekla Healthcare Investors (USD)

ETF | Asset Management | New York Stock Exchange

Last Closing

USD 18.43

Change

0.00 (0.00)%

Market Cap

USD 0.90B

Volume

0.10M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

To achieve long-term capital appreciation by investing at least 80% of its assets in securities of health services and medical technology companies. The Trust may invest up to 20% of its net assets in non-US securities and up to 40% in venture capital or other securities subject to legal or contractual restrictions as to resale.

Inception Date: 23/04/1987

Primary Benchmark: NASDAQ Biotechnology TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 1.03%

Management Expense Ratio:

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-07 )

Largest Industry Peers for Asset Management

Symbol Name Mer Price(Change) Market Cap
BX Blackstone Group Inc 0.00 %

N/A

USD 167.48B
BLK BlackRock Inc 0.00 %

N/A

USD 131.20B
KKR KKR & Co LP 0.00 %

N/A

USD 107.17B
BN Brookfield Corp 0.00 %

N/A

USD 74.47B
APO Apollo Global Management LLC C.. 0.00 %

N/A

USD 65.15B
ARES Ares Management LP 0.00 %

N/A

USD 46.14B
AMP Ameriprise Financial Inc 0.00 %

N/A

USD 43.24B
OWL Blue Owl Capital Inc 0.00 %

N/A

USD 24.29B
RJF Raymond James Financial Inc. 0.00 %

N/A

USD 24.28B
STT-PG State Street Corporation 0.00 %

N/A

USD 18.99B

ETFs Containing HQH

FCEF First Trust Income Opport.. 0.00 % 0.85 %

N/A

USD 0.04B
YYY Amplify High Income ETF 0.00 % 0.50 %

N/A

USD 0.50B

Market Performance

  Market Performance vs. Industry/Classification (Asset Management) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.23% 76% C+ 74% C
Dividend Return 10.02% 97% N/A 98% N/A
Total Return 21.24% 89% A- 87% B+
Trailing 12 Months  
Capital Gain 13.28% 64% D 61% D-
Dividend Return 12.54% 94% A 97% N/A
Total Return 25.81% 83% B 81% B-
Trailing 5 Years  
Capital Gain -0.49% 79% B- 44% F
Dividend Return 50.32% 95% A 96% N/A
Total Return 49.84% 87% B+ 67% D+
Average Annual (5 Year Horizon)  
Capital Gain -2.90% 52% F 24% F
Dividend Return 5.86% 62% D 51% F
Total Return 8.76% 79% B- 94% A
Risk Return Profile  
Volatility (Standard Deviation) 19.16% 38% F 54% F
Risk Adjusted Return 30.57% 61% D- 50% F
Market Capitalization 0.90B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector